Zentalis Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.About ZNTL
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations.
CEOKimberly L. Blackwell
CEOKimberly L. Blackwell
Employees168
Employees168
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2014
Founded2014
Employees168
Employees168
ZNTL Key Statistics
Market cap891.97M
Market cap891.97M
Price-Earnings ratio-2.85
Price-Earnings ratio-2.85
Dividend yield—
Dividend yield—
Average volume767.62K
Average volume767.62K
High today$13.46
High today$13.46
Low today$12.57
Low today$12.57
Open price$13.10
Open price$13.10
Volume376.43K
Volume376.43K
52 Week high$31.46
52 Week high$31.46
52 Week low$9.56
52 Week low$9.56
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%